این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Middle East Journal of Cancer، جلد ۱۳، شماره ۲، صفحات ۱۹۳-۲۱۵
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Currently Used and New Molecular Markers for Thyroid Cancer Diagnosis
چکیده انگلیسی مقاله Thyroid cancer is highly common all around the world. Its prevalence has rapidly increased over the last 30 years in the United States and other developing countries. Fine-needle aspiration biopsy has become the cornerstone of thyroid nodule diagnosis, whose general reliability is outstanding; however, some aspirates have shown undetermined cytological findings that do not provide a definitive malignancy diagnosis. At least 70 molecular and genetic markers in thyroid nodules have been analyzed in an effort to identify molecular markers to differentiate malignant and benign (BN) thyroid nodules. The present review focused on the currently used markers in thyroid cancer diagnosis. A rising number of studies have investigated immunohistochemical markers, such as galectin-3 (GAL3), cytokeratin 19 (CK19), hector battifora mesothelial- 1 (HBME-1), and thyroid peroxidase, along with DNA alterations, including mainly BRAF (B-Raf proto-oncogene, serine/threonine kinase) and RAS (Ras proto-oncogene, GTPase) point mutations, Telomerase reverse transcriptase mutations, ret protooncogene/ papillary thyroid carcinoma and PAX8/PPARG rearrangements, and miRNA signatures and circulating tumor cells for thyroid cancer diagnosis. Although certain markers are promising for differential diagnosis, due to limitations of the substantial prevalence of BN thyroid tumors, none of them is specifically definitive to a large extent. Herein, we also discussed the studies that have supported the use of combinations of several markers, like KIT, TC1, miR-222, and miR-146b combination, as well as GAL3, CK19, and HBME-1 combination, in enhancing the diagnostic accuracy in differentiating malignant and BN tumors.
کلیدواژه‌های انگلیسی مقاله Thyroid cancer, Thyroid nodule, Molecular marker, Prognostic marker
نویسندگان مقاله Hatem A Hejaz |
College of Pharmacy and Medical Sciences, Hebron University, Hebron, Palestine

Isra' Abuzaina |
College of Pharmacy and Medical Sciences, Hebron University, Hebron, Palestine

Reem Naser Aldeen |
College of Pharmacy and Medical Sciences, Hebron University, Hebron, Palestine

Sondos Saad |
College of Pharmacy and Medical Sciences, Hebron University, Hebron, Palestine

نشانی اینترنتی https://mejc.sums.ac.ir/article_48076_00ff4d57a3f93b9597a509a2f6b603c3.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات